Cumberland Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This webpage is a free Sustainability assessment covering Cumberland Pharmaceuticals Inc. Comprehensive ESG assessment of Cumberland Pharmaceuticals Inc can be reached by registering for free. This assessment of Cumberland Pharmaceuticals Inc uses intelligence from across the internet and also from public documents by Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.5; made up of an environmental score of 5.3, social score of 8.0 and governance score of 5.3.
6.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 483 | Provention Bio Inc | 6.6 | High |
| 483 | PuraPharm Corp Ltd | 6.6 | High |
| 511 | Cumberland Pharmaceuticals Inc | 6.5 | High |
| 511 | BPH Energy Ltd | 6.5 | High |
| 511 | Abcam PLC | 6.5 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cumberland Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cumberland Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cumberland Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cumberland Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Cumberland Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cumberland Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cumberland Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.